Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 3.32 USD -6.74% Market Closed
Market Cap: 207.2m USD
Have any thoughts about
Fulcrum Therapeutics Inc?
Write Note

Fulcrum Therapeutics Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fulcrum Therapeutics Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Fulcrum Therapeutics Inc
NASDAQ:FULC
Net Income
-$20.2m
CAGR 3-Years
35%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income
$14.7B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$7.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$12.2B
CAGR 3-Years
27%
CAGR 5-Years
6%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Net Income
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
12%

See Also

What is Fulcrum Therapeutics Inc's Net Income?
Net Income
-20.2m USD

Based on the financial report for Jun 30, 2024, Fulcrum Therapeutics Inc's Net Income amounts to -20.2m USD.

What is Fulcrum Therapeutics Inc's Net Income growth rate?
Net Income CAGR 5Y
21%

Over the last year, the Net Income growth was 79%. The average annual Net Income growth rates for Fulcrum Therapeutics Inc have been 35% over the past three years , 21% over the past five years .

Back to Top